TY - JOUR
T1 - Cancer chemotherapeutic agents.
AU - Terezhalmy, G. T.
AU - Whitmyer, C. C.
AU - Markman, M.
PY - 1996/7
Y1 - 1996/7
N2 - Clinicians, in general, must understand the causes, methods of prevention, management principles, and complications of cancer therapy. They must recognize that patients with cancer require multidisciplinary treatment and coordination of care. The oncologist who manages the patient's care must involve the oral health care provider before the initiation of chemotherapy. The oral health care provider must recognize that cancer chemotherapeutic agents are not selectively tumoricidal and may produce adverse effects by direct toxicity at the cellular level or indirectly, characterized by myeloimmunosuppression, and has the obligation to deliver quality care, competently and timely before, during, and after cancer chemotherapy.
AB - Clinicians, in general, must understand the causes, methods of prevention, management principles, and complications of cancer therapy. They must recognize that patients with cancer require multidisciplinary treatment and coordination of care. The oncologist who manages the patient's care must involve the oral health care provider before the initiation of chemotherapy. The oral health care provider must recognize that cancer chemotherapeutic agents are not selectively tumoricidal and may produce adverse effects by direct toxicity at the cellular level or indirectly, characterized by myeloimmunosuppression, and has the obligation to deliver quality care, competently and timely before, during, and after cancer chemotherapy.
UR - http://www.scopus.com/inward/record.url?scp=0030185645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030185645&partnerID=8YFLogxK
M3 - Review article
C2 - 8829052
AN - SCOPUS:0030185645
VL - 40
SP - 709
EP - 726
JO - Dental Clinics of North America
JF - Dental Clinics of North America
SN - 0011-8532
IS - 3
ER -